431 related articles for article (PubMed ID: 23326142)
1. Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi.
Niu CY; Zhou YL; Yan R; Mu NL; Gao BH; Wu FX; Luo JY
World J Gastroenterol; 2012 Dec; 18(48):7333-40. PubMed ID: 23326142
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination.
Du J; Liu J; Zhang H; Yu CH; Li YM
World J Gastroenterol; 2007 Dec; 13(45):6009-15. PubMed ID: 18023091
[TBL] [Abstract][Full Text] [Related]
3. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
4. [The characteristics of esophagogastric junction contractile index in patients with gastroesophageal reflux disease or functional heartburn].
Wang K; Duan LP; Ge Y; Xia ZW; Xu ZJ
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):283-8. PubMed ID: 27030616
[TBL] [Abstract][Full Text] [Related]
5. Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.
Roorda AK; Marcus SN; Triadafilopoulos G
Dig Dis Sci; 2011 Oct; 56(10):2871-8. PubMed ID: 21512760
[TBL] [Abstract][Full Text] [Related]
6. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
[TBL] [Abstract][Full Text] [Related]
7. A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China.
Wang K; Zhang L; He ZH; Liu ZJ; Zhang L; Hu N; Jin Z; Ke Y; Duan LP
Chin Med J (Engl); 2019 Jul; 132(13):1516-1523. PubMed ID: 31045906
[TBL] [Abstract][Full Text] [Related]
8. Differences in Dietary and Lifestyle Triggers between Non-Erosive Reflux Disease and Reflux Esophagitis-A Multicenter Cross-Sectional Survey in China.
Chen Y; Sun X; Fan W; Yu J; Wang P; Liu D; Song M; Liu S; Zuo X; Zhang R; Hou Y; Han S; Li Y; Zhang J; Li X; Ke M; Fang X
Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571337
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett's esophagus, reflux esophagitis and non-erosive reflux disease].
Wang K; Duan LP; Ge Y; Xu ZJ; Xia ZW
Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1228-32. PubMed ID: 21756791
[TBL] [Abstract][Full Text] [Related]
10. Determinants of symptoms in gastroesophageal reflux disease: nonerosive reflux disease, symptomatic, and silent erosive reflux disease.
Choi JY; Jung HK; Song EM; Shim KN; Jung SA
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):764-71. PubMed ID: 23459104
[TBL] [Abstract][Full Text] [Related]
11. Value of 96-hour ambulatory esophageal pH monitoring in the assessment of patients with refractory acid reflux symptoms and their response to anti-reflux diet.
Triadafilopoulos G; Kamal A; Clarke JO
Dis Esophagus; 2023 Jul; 36(7):. PubMed ID: 36567531
[TBL] [Abstract][Full Text] [Related]
12. Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease.
Lippmann QK; Crockett SD; Dellon ES; Shaheen NJ
Am J Gastroenterol; 2009 Nov; 104(11):2695-703. PubMed ID: 19755967
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia.
Dore MP; Pes GM; Bassotti G; Farina MA; Marras G; Graham DY
Scand J Gastroenterol; 2016 Nov; 51(11):1281-7. PubMed ID: 27381266
[TBL] [Abstract][Full Text] [Related]
14. Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.
Rosaida MS; Goh KL
Eur J Gastroenterol Hepatol; 2004 May; 16(5):495-501. PubMed ID: 15097043
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in oesophageal diseases.
Al Dulaimi D
Gastroenterol Hepatol Bed Bench; 2014; 7(3):186-9. PubMed ID: 25120902
[TBL] [Abstract][Full Text] [Related]
16. Impact of body weight on clinical symptoms and endoscopic changes in patients with gastroesophageal reflux disease.
Krakowska-Stasiak M; Cibor D; Sałapa K; Owczarek D; Mach T
Przegl Lek; 2016; 73(5):271-5. PubMed ID: 29629738
[TBL] [Abstract][Full Text] [Related]
17. [A study on the light microscopic measurement of intercellular space of squamous epithelium in lower-esophagus to diagnose gastroesophageal reflux disease].
Cui RL; Zhou LY; Lin SR; Xue Y
Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):208-12. PubMed ID: 19576088
[TBL] [Abstract][Full Text] [Related]
18. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
19. Study of respiratory disorders in endoscopically negative and positive gastroesophageal reflux disease.
Maher MM; Darwish AA
Saudi J Gastroenterol; 2010; 16(2):84-9. PubMed ID: 20339176
[TBL] [Abstract][Full Text] [Related]
20. Heartburn and regurgitation have different impacts on life quality of patients with gastroesophageal reflux disease.
Lee SW; Lien HC; Lee TY; Yang SS; Yeh HJ; Chang CS
World J Gastroenterol; 2014 Sep; 20(34):12277-82. PubMed ID: 25232262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
